Drug Shortage Report for PROCTODAN-HC SUPPOSITORIES
Report ID | 152074 |
Drug Identification Number | 02240851 |
Brand name | PROCTODAN-HC SUPPOSITORIES |
Common or Proper name | Pramoxine HCl, Hydrocortisone Acetate and Zinc Sulfate hemorrhoidal suppositories |
Company Name | ODAN LABORATORIES LTD |
Market Status | MARKETED |
Active Ingredient(s) | ZINC SULFATE HYDROCORTISONE ACETATE PRAMOXINE HYDROCHLORIDE |
Strength(s) | 10MG 10MG 20MG |
Dosage form(s) | SUPPOSITORY |
Route of administration | RECTAL RECTAL |
Packaging size | 12 |
ATC code | C05AA |
ATC description | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-01-03 |
Estimated end date | 2022-02-16 |
Actual end date | 2022-03-17 |
Shortage status | Resolved |
Updated date | 2022-03-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-03-18 | English | Compare |
v4 | 2022-03-17 | French | Compare |
v3 | 2022-03-17 | English | Compare |
v2 | 2022-01-04 | French | Compare |
v1 | 2022-01-04 | English | Compare |
Showing 1 to 5 of 5